Benefits include: reduced appetite slower gastric emptying improved satiety after meals decreased cravings for sugary and high-fat foods lower blood sugar spikes The GLP-1 effect is fundamental to nearly every modern metabolic drug, but retatrutide does not stop at this single pathway
Key tips for underwriting applicants with GLP1 use Immediately look for: Evidence of the underlying diagnosis (as seen in medical claims, EHR, APS) Whether the GLP-1 is FDA-approved or off-label for that condition Signs of medication adherence (12 months, regular fills) Get cautious when: A GLP1 appears without any supporting clinical context Fills are intermittent or recently initiated Theres no alignment between the medication and expected companion therapies (e.g., no CPAP with sleep apnea) Be confident when: The diagnosis is clear The drug is first line and clinically appropriate Use has been stable long enough to confer benefit Kyle Schimek, PharmD Kyle Schimek is a board-certified pharmacist and Clinical Services Manager at Milliman IntelliScript
A small but growing number of employers (just 2% today) are turning to third party vendors to help them design custom high-performance network offerings
These symptoms typically resolve after days to a few weeks
Hims & Hers CEO Andrew Dudum told investors and analysts on the call that, within six weeks of introducing direct access to Novo Nordisk's GLP-1 products on its platform, the company has fulfilled more than 125,000 shipments for Wegovy products
It was her hormones
